期刊文献+

5-氮杂胞苷对HL60细胞P16、DAPK及MGMT基因甲基化状态影响 被引量:5

Effects of 5-azacytidine on methylation state of P16,DAPK and MGMT genes in HL60 cells
下载PDF
导出
摘要 目的:通过检测5-氮杂胞苷作用于急性早幼粒细胞白血病细胞系(HL60)细胞前后P16、死亡相关蛋白激酶(Deathassociated protein kinase,DAPK)及6-氧-甲基鸟嘌呤-DNA甲基转移酶(O-6-methylguanine-DNA methyltransferase,MGMT)基因甲基化状态的改变及基因表达的变化情况,探讨5-氮杂胞苷对髓系白血病细胞系作用的相关机制。方法:采用常规细胞培养,加入5-氮杂胞苷培养48 h后,以甲基化特异性PCR(Methylation specific PCR,MSP)检测基因甲基化状态,以RT-PCR检测药物作用前后基因表达水平。结果:MSP显示用药前P16基因、DAPK基因及MGMT基因呈高甲基化状态,应用5-氮杂胞苷处理后P16及DAPK基因发生了完全去甲基化,MGMT基因在用药后发生了部分去甲基化;应用5-氮杂胞苷处理前后P16、DAPK及MGMT基因表达强度分别是(0.22±0.04)与(0.64±0.12)、(0.36±0.08)与(1.27±0.09)及(0.75±0.1)与(1.37±0.1),3个基因前后表达强度均有统计学差异(P<0.05)。结论:5-氮杂胞苷通过对P16、DAPK及MGMT甲基化基因的去甲基化作用,使这些基因恢复表达,从而抑制髓系白血病细胞系的增殖,发挥肿瘤细胞增殖抑制作用。 Objective:To explore the effect of 5-azacytidine on myeloid leukemia cell lines through detecting methylation state and expression changes of P16,death associated protein kinase (DAPK) and O-6-methylguanine-DNA methyltransferase(MGMT) after 5-azacytidine treatment for acute promyeloeytic leukemia cell lines(HL60 ceils). Methods:HL60 cells were cultured with 5-azacyti- dine by routine method for 48 h. Then methylation-specific PCR(MSP) and RT-PCR were respectively used to detect gene methyla- tion status and expression changes of P16, DAPKand MGMT before and after being treated with 5-azacytidine. Results:MSP showed hypermethylated P16 ,DAPK and MGMT genes before 5-azacytidine treatment. Complete demethylation was observed in P16 and DAPK genes and partial demethylation was observed in MGMT gene after HL60 cells being co-cultured with 5-azacytidine. Expression intensities of P I6, DAPK and MGMT genes in HL60 ceils before and after treatment of 5-azacytidine were (0.22 ± 0.04) vs. (0.64 ± 0.12), (0.36 ± 0.08) vs. (1.27 ± 0.09) and (0.75 ± 0.1 ) vs. (1.37 ± 0.1) respectively(P〈0.05). Conclusions:The CpG islands of P16, DAPK and MGMT genes are hypermethylated in HL60 cells. 5-azacytidine inhibits proliferation of leukemic cells by demethylation of some related genes.
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2012年第10期864-867,共4页 Journal of Chongqing Medical University
基金 重庆市卫生局科研基金资助项目(编号:渝卫科教34号06-2-193)
关键词 白血病 5-氮杂胞苷 甲基化 基因 leukemia 5-azacytidine methylation gene
  • 相关文献

参考文献13

  • 1Issa J P.DNA methylation as a therapeutic target in cancer[J].Clin Cancer Res, 2007,13 (6) : 1634-1637. 被引量:1
  • 2Ellis L,Atadja P W,Johnstone R W,Epigenetics in cancer: target- ing chromatin modifications[J].Mol Cancer Ther, 2009,8 ( 6 ) : 1409-1420. 被引量:1
  • 3Kaminskas E,Farrell A T,Wang Y C,et al.FDA drug approval sum- mary :azacytidine(5-azacytidine, vidaza) for injectable suspension[J].On- cologist,2005,10(3) : 176-182. 被引量:1
  • 4Fenaux P, Mufti G J, Hellstrooro-Lindberg E,et al.Efficacy of azac- itidine compared with that of conventional care regimens in the treat- ment of higher-risk royelodysplastic syndromes: a randomised,open-la- bel,phase 111 study[J].Lancet Oncol,2009,10(3) :223-232. 被引量:1
  • 5Liu Y, Johnson S M, Fedoriw Y, et aI.Expression of p 16INK4a pre- vents cancer and promotes aging in |ymphocytes[J].B|ood,2011,117(12) : 3257-3267. 被引量:1
  • 6Lin Y, Hupp T R,Stevens C.Death-associated protein kinase (DAPK) and signal transduction: additional roles beyond cell death[J]. FEBS J, 2010,277( 1 ) :48-57. 被引量:1
  • 7Qian J,Wang Y L,Lin J,et al.Aberrant methylation of the death- associated protein kinase 1 (DAPK1) CpG island in chronic myeloid leukemia[J].Eur J Haematol, 2009,82 (2) : 119-123. 被引量:1
  • 8Liu L, Gerson S L.Targeted modulation of MGMT:clinical implica- tions [J].Clin Cancer Res, 2006,12(2) : 328-331. 被引量:1
  • 9Sanchez-Abarca L I,Gutierrez-Cosio S,Santamarta C,et al.Im- munomodulatory effect of 5-azacytidine (5-azaC):potential role in the transplantation setting[J].Blood,2010,115( 1 ) : 107-121. 被引量:1
  • 10Glover A B,Leyland-Jones B.Biochemistry of azacytidine:a review [J].Cancer Treat Rep, 1987,71 (10) : 959-964. 被引量:1

二级参考文献11

  • 1Michael T M,Johann C B,and Paula M V.Cancer DNA methylation:Molecular mechanisms and clinical implications[J].Clin.Cancer Res,2009,15(12):3927-3937. 被引量:1
  • 2Issa J-P J.DNA methylatinn as a therapeutic target in cancer[J].Clinical Cancer Research,2007,13(6):1634-1637. 被引量:1
  • 3Piskala A,Sorm F.5-Azacytidine,a new highly effective cancer ostatic[J].Experientia,1964,20(4):202-203. 被引量:1
  • 4Glover A B,Leyland J B.Biochemistry of azacytidine:a review[J].Cancer Treat Rep,1987,71(10):959-964. 被引量:1
  • 5Kaminskas E.Farrell A.Abraham S,et al.Approval summary:Azacytidine for treatment of myelodysplastic syndrome subtypes[J].Clin Cancer Res,2005,11(10):3604-3608. 被引量:1
  • 6Chitambar C R,Libnoch J A,Matthaeus W G,et al.Evaluation of continuous infusion low dose 5-azacytidine in the treatment of myelodysplastic syndromes[J].Am J Hematol,1991,37(2):100-104. 被引量:1
  • 7Kaminskas E.FDA drug approval summary:azacytidine (5-azacytidine,vidaza (tm))for injectable suspension[J].Oncologist,2005,10(3):176-182. 被引量:1
  • 8Kang D W,Choi C H,Park J Y,et al.Ciglitazone induces caspase independent apoptosis through down regulation of xiap and survivin in human glioma cells[J].Neurochem Res,2008,33(3):551-561. 被引量:1
  • 9Murakami T,Li X,Gong J,et al.Inductinn of apoptosis by 5 azacytidine:drug concentration-dependent differences in cell cycle specificity[J].Cancer Res,1995,55(14):3093-3098. 被引量:1
  • 10Zinzar S,Silverman L R,Richardson E B,et al.Azacytidine plus verapamil induces the differentiation of a newly characterized biophenotypic human myeloid B lymphoid leukemia cell line BW-90[J].Leuk Res,1998,22 (8):677-685. 被引量:1

共引文献1

同被引文献32

  • 1韩颖,罗建民,贾晓辉,王福旭,姚丽,杜行严.急性白血病患者SHP-1与c-kit基因表达及其临床意义[J].中国实验血液学杂志,2006,14(5):867-871. 被引量:7
  • 2Huang K, Shen Y, Xue Z, et al.A panel of CpG methylation sites distinguishes human embryonic stem cells and induced pluripotent stem cells.Stem cell reports,2014,2(1):36-43. 被引量:1
  • 3Choi WS, Seo HS, Song KY, et al.Gastrokine I expression in the humangastric mucosa is closely associated with the degree of gastritis and DNA methylation.Joumal of gastric cancer,2013,13(4):232-241. 被引量:1
  • 4Yan H,Sun J.Methylation status ofWWOX gene promoter CpG islands in epithelial ovarian cancer and its clinical significance.Biomedical reports, 2013,1 (3): 375-378. 被引量:1
  • 5Avruch J, Xavier Ik, Bardeesy N, et al.lkassf family of tumor suppressor polypeptides.The Journal of biological chemistry, 2009, 284(17): 11001-11005. 被引量:1
  • 6Saul Jaime-Figueroa,Javier De Vicente,Johannes Hermann,Alam Jahangir,Sue Jin,Andreas Kuglstatter,Stephen M. Lynch,John Menke,Linghao Niu,Vaishali Patel,Ada Shao,Michael Soth,Minh Diem Vu,Calvin Yee.Discovery of a series of novel 5 H -pyrrolo[2,3- b ]pyrazine-2-phenyl ethers, as potent JAK3 kinase inhibitors[J].Bioorganic & Medicinal Chemistry Letters.2013(9) 被引量:1
  • 7Nilda L. Alicea-Velázquez,Jean Jakoncic,Titus J. Boggon.Structure-guided studies of the SHP-1/JAK1 interaction provide new insights into phosphatase catalytic domain substrate recognition[J].Journal of Structural Biology.2013(3) 被引量:1
  • 8Elisa Leo,Manuela Mancini,Michela Aluigi,Fausto Castagnetti,Giovanni Martinelli,Enza Barbieri,Maria A. Santucci.DNA hypermethylation promotes the low expression of pro‐apoptotic BCL2L11 associated with BCR ‐ ABL1 fusion gene of chronic myeloid leukaemia[J].Br J Haematol.2012(3) 被引量:1
  • 9George R. Stark,James E. Darnell.The JAK-STAT Pathway at Twenty[J].Immunity.2012(4) 被引量:1
  • 10Agnieszka Witkiewicz,Puthiyaveettil Raghunath,Agnieszka Wasik,Jacqueline M. Junkins-Hopkins,Dan Jones,Qian Zhang,Niels Odum,Mariusz A. Wasik.Loss of SHP-1 tyrosine phosphatase expression correlates with the advanced stages of cutaneous T-cell lymphoma.[J].Human Pathology.2007(3) 被引量:1

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部